Attached files
| file | filename |
|---|---|
| 8-K - CURRENT REPORT - NeuBase Therapeutics, Inc. | ohrp_8k.htm |
| EX-99.1 - PRESS RELEASE - NeuBase Therapeutics, Inc. | ohrp_ex991.htm |
| EX-10.17 - EMPLOYMENT AGREEMENT - NeuBase Therapeutics, Inc. | ohrp_ex1017.htm |
Exhibit 10.16
Ohr
Pharmaceutical, Inc
1245
Brickyard Road, #590
Salt lake
City, Utah 84106
801-433-2000
ph
801-433-2222
fx
February
25, 2010
Dr. Irach
Taraporewala
9009 N Fm
620
Austin,
TX 78726
Dear
Irach:
On behalf
of Ohr Pharmaceutical Inc., I am pleased to offer you employment as Chief
Executive Officer for Ohr, reporting to the Board of Directors. Your
base salary will be at a bi-weekly rate of $5000.00 which is annualized at a
rate of $130,000. Your start date will be Monday, April 12,
2010
You will
be granted incentive stock options to purchase 800,000 shares of Ohr common
stock at $0.50, 400,000 options will vest immediately upon your employment and
the rest will vest on an annual basis of 100,000 options per installment whole
employed at Ohr.
Your
employment will renew automatically on an annual basis. This is the full and
complete agreement between us on this term. This provision can only
be modified in writing signed by both you and an officer of the
Company.
Your
employment pursuant to this offer is contingent on you signing a Proprietary
Information and Inventions Agreement, covering the ownership of any intellectual
property developed by you and confidentiality obligations.
We very
much hope that you will accept our offer and look forward to having you on the
team.
Sincerely
yours,
Andrew
Limpert
Interim
CEO
I accept
the offer of employment above.
Name
Date